-
-
Overview
-
Specificity: Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Panitumumab.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Isotype Control: Bulk Human IgG2 Isotype Control (IB2) [ICH2255]
Endotoxin: ≤ 0.75 EU/mg as determined by the LAL methodPlease contact us at for specific academic pricing.
Background
Panitumumab biosimilar is a recombinant, human IgG2 kappa monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). It has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
-
- Properties
-
Overview